ARK Genomic Revolution ETF
ARKG
Updated: 24/09/2026, 09:02:30
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
No summaries found.
- Share price
- $50.92
- Market cap
- $1.78B
- Exchange
- CBOE
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 31/10/2014
- Beta
- 2.38
- Last dividend
- $0.00
- Day range
- $50.66 – $53.00
- 52-week range
- $24.60 – $53.41
- 1-day performance
- -3.69%
- 1-year performance
- 106.99%
- Current drawdown (1Y)
- -4.65%
- CIK
- 0001579982
- CUSIP
- 00214Q302
- ISIN
- US00214Q3020
- Created
- 07/12/2025, 02:08:34
- Last update
- 24/09/2026, 09:02:30
Track ARK Genomic Revolution ETF with an AI analyst
See which prediction-market events move ARKG, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.